MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.transproceed.2025.09.012

Медицинская библиотека · Transplantation proceedings · 2025

Incidence of Post-Transplantation Major Adverse Cardiovascular Events in Lung Transplant Recipients With No Prior Cardiovascular Disease.

Shostak Yael, Kramer Mordechai R, Sternbach Neta, Pertzov Barak, Shitenberg Dorit, Amor Shay M, Heching Moshe, Rosengarten Dror, Bakal Ilana, Skalsky Keren, Eisen Alon, Peysakhovich Yuri, Barac Yaron D, Shlomai Amir, Shtraichman Osnat

СтатьяПеревод в очереди

Аннотация

BACKGROUND AND AIMS: Cardiovascular disease (CVD) is a significant concern after solid organ transplantation, partly due to the adverse effects of immunosuppressive therapy. However, the incidence of major adverse cardiovascular events (MACE) in patients without prior CVD among this population is not well understood. This study aimed to evaluate the occurrence of MACE in lung transplant recipients (LTRs) without pre-existing CVD.

MATERIALS AND

METHODS

We reviewed retrospectively LTRs without known CVD between 2003 and 2019. MACE outcomes included acute coronary syndrome, revascularization, cerebrovascular events, peripheral vascular disease, and cardiovascular mortality.

RESULTS

Of 342 LTRs (median 55.0 (41.0, 61.0); 42.2% female), 16 (4.7%) developed MACE over a median follow-up of 54.5 months. Logistic regression analysis demonstrated a significant association between developing two or more post-transplant risk factors for CVD, such as HTN and DM, and an increased likelihood of MACE (OR 5.672, CI 1.092-29.464, P = .039). There was a trend toward higher mortality in the MACE group, 62.5%, compared to 39.0% in the control group (P = .0707). COX regression analysis showed that single lung transplantation was significantly associated with poorer survival (HR 1.762, 95% CI 1.135-2.73, P = .0116). Older age and CKD showed a trend toward higher mortality (HR 1.013, P = .1681; HR 1.369, P = .092, respectively).

CONCLUSION

MACE incidence was low in this large cohort of LTRs without pre-transplant CVD. Developing two or more post-transplant CVD risk factors was associated with an increased risk for MACE, highlighting the importance of rigorous post-transplant management to mitigate MACE risk.

Для цитирования: Shostak Yael, Kramer Mordechai R, Sternbach Neta, Pertzov Barak, Shitenberg Dorit, Amor Shay M, Heching Moshe, Rosengarten Dror, Bakal Ilana, Skalsky Keren, Eisen Alon, Peysakhovich Yuri, Barac Yaron D, Shlomai Amir, Shtraichman Osnat. Incidence of Post-Transplantation Major Adverse Cardiovascular Events in Lung Transplant Recipients With No Prior Cardiovascular Disease.. Transplantation proceedings. 2025. DOI: 10.1016/j.transproceed.2025.09.012.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.